Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
7,125
datasets available to search
ShareScore release 0.8.0
Dataset results
7,125 results for “prostate cancer”
Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer
ClinicalTrials.gov study NCT05617040. IPD Sharing: NO. Countries: 1. Publications: 0.
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
ClinicalTrials.gov study NCT02012296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
ClinicalTrials.gov study NCT00838201. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov study NCT00276549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
ClinicalTrials.gov study NCT00176644. IPD Sharing: NO. Countries: 1. Publications: 0.
SHIP (Selinexor in Hormone Insensitive Prostate Cancer)
ClinicalTrials.gov study NCT02146833. IPD Sharing: YES. Countries: 1. Publications: 0.
Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov study NCT00483561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
ClinicalTrials.gov study NCT01081873. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
ClinicalTrials.gov study NCT00925600. IPD Sharing: Not stated. Countries: 18. Publications: 0.
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT07189403. IPD Sharing: YES. Countries: 3. Publications: 0.
Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT06866548. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension
ClinicalTrials.gov study NCT04907227. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer
ClinicalTrials.gov study NCT00108732. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)
ClinicalTrials.gov study NCT00777959. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov study NCT00786682. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
ClinicalTrials.gov study NCT01560923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer
ClinicalTrials.gov study NCT03366792. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer
ClinicalTrials.gov study NCT03432780. IPD Sharing: NO. Countries: 0. Publications: 9.
GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
ClinicalTrials.gov study NCT01420861. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
ClinicalTrials.gov study NCT01313273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.